Correlation Between Syndax Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Eliem Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Eliem Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Syndax and Eliem is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.3 times more return on investment than Eliem Therapeutics. However, Syndax Pharmaceuticals is 1.3 times more volatile than Eliem Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 1,921 in Syndax Pharmaceuticals on August 28, 2024 and sell it today you would lose (248.00) from holding Syndax Pharmaceuticals or give up 12.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Eliem Therapeutics
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Eliem Therapeutics |
Syndax Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Syndax Pharmaceuticals vs. Eliem Therapeutics | Syndax Pharmaceuticals vs. HCW Biologics | Syndax Pharmaceuticals vs. Scpharmaceuticals | Syndax Pharmaceuticals vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |